Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Graefe's Archive for Clinical and Experimental Ophthalmology

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00417-011-1856-9PMID 22081232PMCID PMC3673018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiplex analysis of age‐related protein and lipid modifications in human Bruch's membrane

  2010cited by this paper
• Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system.

  2010cited by this paper
• Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.

  2009cited by this paper
• Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.

  2009cited by this paper
• Protein expression profiling during chick retinal maturation: a proteomics-based approach

  2008cited by this paper
• Age‐dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice

  2008cited by this paper
• Proteomic and transcriptomic analyses of retinal pigment epithelial cells exposed to REF-1/TFPI-2.

  2007cited by this paper
• α-Crystallin distribution in retinal pigment epithelium and effect of gene knockouts on sensitivity to oxidative stress

  2007cited by this paper
• Vimentin Is the Specific Target in Skin Glycation

  2007cited by this paper
• RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.

  2007cited by this paper
• Vimentin is the specific target in skin glycation. Structural prerequisites, functional consequences, and role in skin aging.

  2007cited by this paper
• Proteomic and phototoxic characterization of melanolipofuscin: Correlation to disease and model for its origin

  2007cited by this paper
• Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration.

  2007cited by this paper
• Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging

  2007cited by this paper
• High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells.

  2006cited by this paper
• Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration.

  2006cited by this paper
• Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors.

  2006cited by this paper
• The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas.

  2006cited by this paper
• Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival.

  2006cited by this paper
• Examining the proteins of functional retinal lipofuscin using proteomic analysis as a guide for understanding its origin.

  2005cited by this paper
• Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells.

  2005cited by this paper
• Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats

  2005cited by this paper
• Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor

  2004cited by this paper
• Receptor for advanced glycation end products and age-related macular degeneration.

  2004cited by this paper
• Current concepts in the pathogenesis of age-related macular degeneration.

  2004cited by this paper
• Preparation of planar retinal specimens: verification by histology, mRNA profiling, and proteome analysis.

  2004cited by this paper
• Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium.

  2003cited by this paper
• Protein Database, Human Retinal Pigment Epithelium*

  2003cited by this paper
• Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells.

  2003cited by this paper
• Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.

  2003cited by this paper
• Identification of protein disulfide isomerase as an endothelial hypoxic stress protein.

  2002cited by this paper
• Drusen proteome analysis: An approach to the etiology of age-related macular degeneration

  2002cited by this paper
• Phenotypic variation of retinal pigment epithelium in age-related macular degeneration.

  2002cited by this paper
• Ubiquitylation of the transducin betagamma subunit complex. Regulation by phosducin.

  2002cited by this paper
• Role of Ubiquilin Associated with Protein-disulfide Isomerase in the Endoplasmic Reticulum in Stress-induced Apoptotic Cell Death*

  2002cited by this paper
• Ubiquitylation of the Transducin βγ Subunit Complex

  2002cited by this paper
• Proteome analysis of lipofuscin in human retinal pigment epithelial cells

  2002cited by this paper
• Nicotine protects against arachidonic‐acid‐induced caspase activation, cytochrome c release and apoptosis of cultured spinal cord neurons

  2001cited by this paper
• Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

  2001cited by this paper
• Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia.

  2001cited by this paper
• Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro.

  2001cited by this paper
• Up-regulation of Protein-disulfide Isomerase in Response to Hypoxia/Brain Ischemia and Its Protective Effect against Apoptotic Cell Death*

  2000cited by this paper
• The relationships of age changes in retinal pigment epithelium and Bruch's membrane.

  1999cited by this paper
• Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.

  1999cited by this paper
• Involvement of calcium in retinal pigment epithelial cell proliferation and pigmentation.

  1998cited by this paper
• Advanced glycation end products in age-related macular degeneration.

  1998cited by this paper
• Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes

  1997cited by this paper
• Immunolocalization of ubiquitin and related enzymes in human retina and retinal pigment epithelium

  1997cited by this paper
• Ubiquitin-dependent protein degradation.

  1996cited by this paper
• Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens.

  1995cited by this paper
• Effects of pharmacological modulation of intracellular signalling systems on retinal pigment epithelial cell attachment to extracellular matrix proteins.

  1995cited by this paper
• Protein disulfide isomerase exhibits chaperone and anti-chaperone activity in the oxidative refolding of lysozyme.

  1994cited by this paper
• Correlation between lipids extracted from Bruch's membrane and age.

  1993cited by this paper
• Maillard Reaction-Mediated Molecular Damage to Extracellular Matrix and Other Tissue Proteins in Diabetes, Aging, and Uremia

  1992cited by this paper
• Collagen and ageing in Bruch's membrane.

  1991cited by this paper
• Aging changes in Bruch's membrane. A histochemical and morphologic study.

  1990cited by this paper
• Ubiquitin carboxyl‐terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases

  1990cited by this paper
• The prevalence of macular drusen in postmortem eyes.

  1986cited by this paper

• Gain-of-Function Variant in STAT3 and Retinal Macular Edema: Insights into the IL-6 R/JAK/STAT3 Pathway in Retinal Pigment Epithelium

  2025cites this paper
• Novel Possible Protein Targets in Neovascular Age-Related Macular Degeneration: A Pilot Study Experiment

  2022cites this paper
• Introductory Chapter: Macular Degeneration: Mechanisms of Action

  2020cites this paper
• Identification of surrogate anatomic identifiers of disease progression in age-related macular degeneration

  2019cites this paper
• Análise molecular por espectrometria de massas de pacientes com degeneração macular relacionada à idade do tipo neovascular (DMRIn) resistentes ao anti-VEGF

  2019cites this paper
• Molecular Response of Retinal Pigment Epithelial Cells to Oxidized Lipoproteins: Global and Targeted Studies

  2018cites this paper
• Advanced glycation end products‐related modulation of cathepsin L and NF‐κB signalling effectors in retinal pigment epithelium lead to augmented response to TNFα

  2018influential citation
• Proteomics of Human Retinal Pigment Epithelium (RPE) Cells

  2018cites this paper
• NLRP3 inflammasome activity in RPE : role in AMD pathogenesis

  2017cites this paper
• Redox proteomics: Methods for the identification and enrichment of redox‐modified proteins and their applications

  2016cites this paper
• A local complement response by RPE causes early-stage macular degeneration.

  2015cites this paper
• NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration

  2015cites this paper
• Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases.

  2014influential citation
• Oxidative Stress Protection by Exogenous Delivery of rhHsp70 Chaperone to the Retinal Pigment Epithelium (RPE), a Possible Therapeutic Strategy Against RPE Degeneration

  2014cites this paper
• NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ARE ANTI-INFLAMMATORY AND TARGET DRY AGE-RELATED MACULAR DEGENERATION

  2014cites this paper
• Age-related changes of cystatin C expression and polarized secretion by retinal pigment epithelium: potential age-related macular degeneration links.

  2014cites this paper
• Retinal Microenvironment Imbalance in Dry Age-Related Macular Degeneration: A Mini-Review

  2013cites this paper
• Current world literature.

  2013cites this paper
• The Ubiquitin–Proteasome System in Retinal Health and Disease

  2013cites this paper
• Aging is not a disease: distinguishing age-related macular degeneration from aging.

  2013cites this paper
• Advanced glycation endproducts and its receptor for advanced glycation endproducts in World

  2013cites this paper
• Mechanisms of age-related macular degeneration.

  2012cites this paper
• Complement dysregulation in AMD: RPE-Bruch's membrane-choroid.

  2012cites this paper
• WITHDRAWN: Complement dysregulation in AMD: RPE-Bruch's membrane-choroid.

  2012cites this paper
• Mechanisms for countering oxidative stress and damage in retinal pigment epithelium.

  2012cites this paper